Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FP1DV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,481
Award facts
- Contract value 100% obligated
- $11,481.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,481.02 to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Vraylar 1.5 mg capsules (30-count unit). The contract utilizes firm fixed pricing with an ultimate completion date of November 26, 2025, and was awarded on a competitive basis without set-aside restrictions. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the federal government's medical supply chain, with particular focus on supporting military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to deliver a wide range of pharmaceutical products, including neurological treatments such as Vraylar, across multiple therapeutic domains. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm's competitive awards and consistent delivery of medical commodities establish it as a significant vendor within the federal procurement landscape for pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26FP1DV?
SPE2DR26FP1DV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FP1DV worth?
The government has obligated $11,481 on SPE2DR26FP1DV.
Is contract SPE2DR26FP1DV an order under another contract?
Yes. SPE2DR26FP1DV is a delivery order under SPE2DR25D3014, an indefinite delivery contract.
Was contract SPE2DR26FP1DV competed?
The extent of competition for SPE2DR26FP1DV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award